NCT00160901View on ClinicalTrials.gov

Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

December 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

two complex naturopathic add-on therapies, leaflet 5-a-day

Trial Locations (1)

D-69115

Department of Complementary and Integrative Medicine, Heidelberg

All Listed Sponsors
collaborator

Hector-Stiftung

OTHER

collaborator

Cefak KG, Kempten

UNKNOWN

collaborator

Ursapharm, Saarbrücken

UNKNOWN

collaborator

Schwabe-Wenex International Ltd

INDUSTRY

lead

Heidelberg University

OTHER

NCT00160901 - Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter